The UK could soon be the first country in the world to licence e-cigarettes or vapes as a medicinal product available on prescription in an effort to help people stop smoking.The news from the Medicines and Healthcare Products Regulatory Authority sent shares in medical cannabis firm Kanabo (KNB) soaring more than 6%, although the rest of the sector barely flickered and the large tobacco...

Like all new investment themes, medicinal cannabis - which uses cannabidiol or CBD rather than the psychoactive THC component of the cannabis sativa plant - has had its highs and lows in the early stages of its development.Over the past five years, shares in CBD companies have been through two distinct waves of interest. Today, with consumers showing a more educated approach to CBD and high...

London's FTSE 100 firmed 0.15% to 7,120.45 early on Friday, with energy stocks leading the way, following the announcement of US President Joe Biden's $952 billion bipartisan infrastructure agreement.Large government spending plans once again came to the rescue of the markets, with US stocks racing ahead last night, which drove gains across Asia on Friday.US banks also passed their stress...

There are good reasons to be excited by the prospects for the global cannabis industry as more countries legalise recreational usage and a plethora of new medical applications are developed.In addition, an increasing number of cannabis-based consumer products are slated to enter the market over the next few years which should help to bring cannabis into the mainstream.According to consultancy...